Pheon Therapeutics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$151M
- Investors
-
11
Pheon Therapeutics General Information
Description
Developer of antibody-drug conjugates designed to treat hard-to-treat solid tumors. The company's pipeline utilizes novel targets and proprietary linker-payload technologies to facilitate the creation of first-in-class oncology assets, enabling healthcare providers to access next-generation therapies for cancer types that have not responded to conventional treatments.
Contact Information
Website
www.pheontx.comCorporate Office
- Innovation House, Innovation Way
- Discovery Park
- CT13 9FF
- England, United Kingdom
Corporate Office
- Innovation House, Innovation Way
- Discovery Park
- CT13 9FF
- England, United Kingdom
Pheon Therapeutics Timeline
Pheon Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 21-May-2024 | $151M | Completed | Clinical Trials - Phase 1 | ||
| 4. Later Stage VC (Series A2) | 04-Mar-2024 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC (Series A) | 31-Jan-2018 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 19-Oct-2015 | $3.53M | $3.53M | Completed | Startup | |
| 1. University Spin-Out | 08-Jul-2015 | Completed | Startup |
Pheon Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A 2 Preferred | ||||||||
| Series A 2 Preferred | 25,046,180 | $0.000125 | $2.38 | $2.38 | 1x | $2.38 | 44.36% | |
| Series A | 3,800,000 | $0.000125 | $1.25 | $1.25 | 1x | $1.25 | 6.73% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Pheon Therapeutics Comparisons
Industry
Financing
Details
Pheon Therapeutics Competitors (9)
One of Pheon Therapeutics’s 9 competitors is Sotio Biotech, a Pending Transaction (VC) company based in Prague, Czech Republic.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sotio Biotech | Pending Transaction (VC) | Prague, Czech Republic | ||||
| STORM Therapeutics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Myricx Bio | Formerly VC-backed | London, United Kingdom | ||||
| Araris | Formerly VC-backed | Zurich, Switzerland |
Pheon Therapeutics Patents
Pheon Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026105061-A1 | Antibody-drug conjugates that bind cdcp1 and uses thereof | Pending | 15-Nov-2024 | ||
| WO-2026078443-A1 | Antibody drug conjugates that bind cdcp1 and uses thereof | Pending | 11-Oct-2024 | ||
| WO-2025262641-A1 | Antibody drug conjugates that bind cdcp1 and uses thereof | Pending | 19-Jun-2024 | ||
| WO-2025149667-A1 | Antibody drug conjugates and uses thereof | Inactive | 12-Jan-2024 | ||
| AU-2023393437-A1 | Antibodies to cub domain-containing protein 1 (cdcp1) and uses thereof | Pending | 16-Dec-2022 | A61P35/00 |
Pheon Therapeutics Signals
Pheon Therapeutics Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BVF Partners | Hedge Fund | Minority | ||
| Lightspeed Venture Partners | Venture Capital | Minority | ||
| Perceptive Advisors | Venture Capital | Minority | ||
| TCG Crossover Management | Venture Capital | Minority | ||
| Atlas Venture | Venture Capital | Minority |
Pheon Therapeutics FAQs
-
When was Pheon Therapeutics founded?
Pheon Therapeutics was founded in 2015.
-
Where is Pheon Therapeutics headquartered?
Pheon Therapeutics is headquartered in United Kingdom.
-
What is the size of Pheon Therapeutics?
Pheon Therapeutics has 31 total employees.
-
What industry is Pheon Therapeutics in?
Pheon Therapeutics’s primary industry is Drug Discovery.
-
Is Pheon Therapeutics a private or public company?
Pheon Therapeutics is a Private company.
-
What is the current valuation of Pheon Therapeutics?
The current valuation of Pheon Therapeutics is .
-
What is Pheon Therapeutics’s current revenue?
The current revenue for Pheon Therapeutics is .
-
How much funding has Pheon Therapeutics raised over time?
Pheon Therapeutics has raised $222M.
-
Who are Pheon Therapeutics’s investors?
BVF Partners, Lightspeed Venture Partners, Perceptive Advisors, TCG Crossover Management, and Atlas Venture are 5 of 11 investors who have invested in Pheon Therapeutics.
-
Who are Pheon Therapeutics’s competitors?
Sotio Biotech, STORM Therapeutics, Adaptimmune Therapeutics, Myricx Bio, and Araris are some of the 9 competitors of Pheon Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process